关键词： GSK A*STAR 合作协议
2013年4月10日讯 /生物谷BIOON/ --制药巨头GlaxoSmithKline公司与新加坡的A*STAR下属的Institute of Chemical and Engineering Sciences（ICES）达成一项为期五年的研发合作协议。该合作将集中在研究新型定制药物领域。
GSK和A*STAR合作已达十年之久，ICES的Dr Keith Carpenter表示与GSK的合作能够加强公司在研发方面的实力。（生物谷Bioon.com）
详细英文报道：
Pharma giant GlaxoSmithKline ($GSK) has inked a 5-year research pact with A*STAR's Institute of Chemical and Engineering Sciences (ICES) in Singapore, promising to collaborate on researching newly formulated drugs. The two groups have been working together for the past decade, helping build the city-state's reputation for R&D. "Collaborating with GSK, a global leader in pharmaceuticals and healthcare provides an opportunity for us to further our research and deepen our capabilities in formulation science with skilled scientists and technical expertise. This venture will enable us to develop future scientists and laboratory analysts with the right skills to grow this industry in Singapore," said Dr Keith Carpenter, the executive director of ICES.
